US Patent Issued to CRAGE MEDICAL on Sept. 1 for "Anti-claudin 18.2 antibody and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,098, issued on Sept. 1, was assigned to CRAGE MEDICAL Co. Ltd. (Hong Kong).

"Anti-claudin 18.2 antibody and use thereof" was invented by Zonghai Li (Xuhui District Shanghai, China), Peng Wang (Xuhui District Shanghai, China), Zhen Liu (Xuhui District Shanghai, China) and Huamao Wang (Xuhui District Shanghai, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is an antibody or antigen binding fragment, capable of recognizing an antigen peptide comprising SEQ ID NO: 7 (KNKKIYDGG); or recognizing an epitope comprising SEQ ID NO: 7 in Claudin 18.2; preferably recognizing a peptide comprising SEQ ID NO: 6 (KNKKIYDGGART); or recognizing an epit...